EUVIMEDEUVIMED entdecken
Open Access

Prelamin A in an Lmna L648R/L648R Mouse Model Does Not Promote Atherosclerosis or Vascular Smooth Muscle Loss

Yuexia Wang iD, Leroy C Joseph, Cecilia Östlund, George Kuriakose, Wei Hsu iD, Susan Michaelis iD, Howard J Worman iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.126.324400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Yuexia Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Y.W., L.C.J., C.Ö., G.K., H.J.W.), Vagelos College of Physicians and Surgeons, Columbia University, New York. Hauptthemen laut MEDLINE: Lamin Type A, Muscle, Smooth, Vascular, Atherosclerosis, Progeria. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hutchinson-Gilford progeria syndrome is an accelerated aging disorder characterized by numerous symptoms, including early onset atherosclerosis, myocardial infarctions, and strokes. Hutchinson-Gilford progeria syndrome is caused by mutations in LMNA that lead to expression of an internally truncated, farnesylated prelamin A variant called progerin, which induces loss of vascular smooth muscle cells. Some studies have also reported that accumulation of full-length farnesylated prelamin A, which is normally completely processed to mature nonfarnesylated lamin A, can also drive vascular pathology during physiological aging. METHODS: To assess the effects of prelamin A expression on atherosclerosis and aortic media vascular smooth muscle cells, we used Lmna L648R/L648R mice that express a prelamin A variant with a lysine to arginine point mutation that prevents its processing to mature lamin A. We previously demonstrated bone defects, reduced body fat, and low body mass in these mice, similar to Hutchinson-Gilford progeria syndrome model mice. To determine if prelamin A expression has an impact on atherosclerotic plaques, we crossed Lmna L648R/L648R mice to low-density lipoprotein receptor-deficient Ldlr −/− mice that develop hyperlipidemia on a high-fat diet. RESULTS: Atherosclerotic plaque lesion area and necrotic core area were not different in hyperlipidemic Lmna L648R/L648R mice that expressed only prelamin A, and no mature lamin A, compared with hyperlipidemic Lmna +/+ mice that expressed only fully processed mature lamin A and no prelamin A. Additionally, exclusive prelamin A expression did not result in loss of aortic vascular smooth muscle cells or adventitial thickening in hyperlipidemic Lmna L648R/L648R mice with atherosclerosis at 28 weeks of age. Indeed, aortic vascular smooth muscle remained normal in older Lmna L648R/L648R mice at 52 weeks of age. There were no differences in proliferation or apoptosis of aortic media cells. CONCLUSIONS: In contrast to the prelamin A variant progerin expressed in Hutchinson-Gilford progeria syndrome, prelamin A does not appear to cause vascular smooth muscle loss, promote atherosclerosis, or drive vascular aging in Lmna L648R/L648R mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lamin Type AMuscle, Smooth, VascularAtherosclerosisProgeriaAortic DiseasesMyocytes, Smooth MuscleProtein PrecursorsAnimalsDisease Models, AnimalPlaque, AtheroscleroticMice, Inbred C57BLPhenotypeMiceApoptosisAortaCell ProliferationMaleCells, CulturedReceptors, LDLNecrosisPoint MutationMice, Transgenic

Stichwörter der Autor:innen

apoptosisatherosclerosishyperlipidemiaslaminsmyocardial infarctionpoint mutationprogeria

Substanzen

Lamin Type ALmna protein, mouseprelamin AProtein PrecursorsReceptors, LDL

Autor:innen und Institutionen

  • Department of Medicine (Y.W., L.C.J., C.Ö., G.K., H.J.W.), Vagelos College of Physicians and Surgeons, Columbia University, New York.
  • Department of Pathology and Cell Biology (Y.W., C.Ö., H.J.W.), Vagelos College of Physicians and Surgeons, Columbia University, New York.
  • Department of Craniofacial Biology and Bioengineering, The ADA Forsyth Institute, Somerville, MA (W.H.).
  • Department of Developmental Biology, Harvard School of Dental Medicine, Harvard University, Boston, MA (W.H.).
  • Department of Developmental Biology, Faculty of Medicine, Harvard University, Boston, MA (W.H.).
  • Harvard Stem Cell Institute, Harvard University, Cambridge, MA (W.H.).

ORCID-Profile: Yuexia Wang, Wei Hsu, Susan Michaelis, Howard J Worman

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Wang, Y., Joseph, L. C., Östlund, C., Kuriakose, G., Hsu, W., Michaelis, S., & Worman, H. J. (2026). Prelamin A in an Lmna L648R/L648R Mouse Model Does Not Promote Atherosclerosis or Vascular Smooth Muscle Loss. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.324400

Vancouver

Wang Y, Joseph LC, Östlund C, Kuriakose G, Hsu W, Michaelis S, et al. Prelamin A in an Lmna L648R/L648R Mouse Model Does Not Promote Atherosclerosis or Vascular Smooth Muscle Loss. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.324400

BibTeX
@article{Wang2026,
  author = {Wang, Yuexia and Joseph, Leroy C and Östlund, Cecilia and Kuriakose, George and Hsu, Wei and Michaelis, Susan and Worman, Howard J},
  title = {Prelamin A in an Lmna L648R/L648R Mouse Model Does Not Promote Atherosclerosis or Vascular Smooth Muscle Loss},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.126.324400}
}
Kostenlos starten →